glp 1 drugs blindness Lawsuits claiming Ozempic, other GLP-1s led to become second mass litigation over the GLP-1 Weight Loss Drugs linked
Description
Failure to warn
In vivo studies Animals The animal experiments were approved by the Animal Care and Use Committee of Peking University and were conducted in accordance with national and international guidelines
On the heart and circulation, the Phase 2 data show consistent reductions in resting blood pressure of approximately 5 to 8 mmHg at the higher doses, alongside large improvements in the cholesterol pattern most associated with heart disease
10.1038/s41580-021-00390-6 42 JastreboffA
doi: 10.1007/s40273-015-0264-0
